Stephan Abel

Title: Innovations and Contributions of Inventor Stephan Abel

Introduction

Stephan Abel is a notable inventor based in Weil am Rhein, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhalation therapies. With a total of 10 patents to his name, his work has had a considerable impact on medical formulations.

Latest Patents

One of his latest patents involves compositions of glycopyrronium salt for inhalation. This patent describes a process for preparing dry powder formulations of glycopyrronium salt that exhibit good stability. The process includes micronising a glycopyrronium salt with an anti-adherent agent and admixing carrier particles to create the dry powder formulation. Another significant patent focuses on N-phenyl-2-pyrimidine-amine derivatives, which relates to novel amides and the process for preparing these amides.

Career Highlights

Throughout his career, Stephan Abel has worked with prominent companies, including Novartis AG. His expertise in pharmaceutical formulations has positioned him as a key player in the industry, contributing to advancements in inhalation therapies.

Collaborations

Stephan has collaborated with several professionals in his field, including Mark Meisenbach and Olivier Loiseleur. These collaborations have further enhanced his innovative work and contributed to the success of his projects.

Conclusion

Stephan Abel's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in inhalation therapies and medical formulations.